Latest Stock Buy or Sell? Make More Informed Decisions!

Today, Christine Poole commented about whether SYK, RTX, MSFT, NFLX, ZTS, NVDA, TMO, OTIS, CNR.TO, ABT, SHOP.TO, ATZ.TO, CLS.TO, MCD, FTT.TO, XYL, CP.TO, BAC, CAT are stocks to buy or sell.

COMMENT
US markets.

October was an interesting month. Prior to that the market was very narrow, led by large-cap tech stocks.

But in October, the (market-cap weighted) S&P 500 was down about 1%. But the equal-weight index was actually up almost 5%. Quite a gap in performance. That tells her that the breadth is broadening, stock in sectors other than large tech are doing quite well. 

So there was a rotation in the market. Investors didn't necessarily sell the market. They just rotated away from tech and semiconductors toward healthcare and even utilities. Toward things that are more defensive.

That's encouraging. Historically, a bull market is healthier if it's more broad-based.

COMMENT
Names in the power space have come down.

Exactly. A lot of the industrial names that supply the data centre buildout have pulled back on fears that the buildout will slow, product demand won't be as great, and profits will suffer.

Pullback is healthy, as a lot of those names were trading at very high multiples.

COMMENT
Anthropic.

There's a lot of topline growth, but they're not making money right now. They do have cash, and they'll raise more from the IPO.

HOLD

Peaked out in July, now 45% off highs. The classic cyclical. Data centre buildout will change this to secular growth. Pulled back when pace of AI buildout came into question.

Multiple's now more reasonable, ~22x forward PE. Huge backlog, no cancellations so far. Will generate a lot of FCF. If demand fades, earnings will eventually roll over.

WEAK BUY

Fines and regulatory concerns, but they'll work through it. Reasonable valuation. US economy doing well so far. You could enter here.

Disclaimer:  Christine doesn't own BAC. Her colleague John O'Connell does in his US-focused fund.

HOLD

Mexican trade routes are very lucrative. Likes the rail industry in general, with its oligopolistic nature. If economics improve in 
Canada, rails will benefit.

She owns CNR instead.

BUY

Missed a few quarters, municipal funding issues on horizon. Benefited from renewable theme when Democrats were in power, but that faded. At $150, high multiple.

Believes in water long term -- scarce resource, EMs need to build out their infrastructure, modernize and repair in developed countries.

PARTIAL SELL
Slight miss on earnings. Lighten up?

Similar chart to CAT. Both suffering from fears of slowing data centre buildout. Between the two, she'd choose CAT. In Canada, further exploration in minerals or energy should be beneficial.

Good run. If you haven't already, take some $$ off the table.

HOLD

Feeling impact of lower- and middle-income consumer; value menu tweaks will take time. Traffic is soft. US economy is K-shaped. Helping frachisees upgrade restaurants. Sees room to grow its chicken market, but equipment needs to be retooled.

Still likes it. Economies of scale, synergies, gets rent from many franchisees (a recurring cashflow stream).

DON'T BUY

Not inexpensive. Already corrected. If pace of buildout slows, stock price will be impacted.

BUY ON WEAKNESS

In client growth portfolios. Executing very well. Great potential growth in US. Opening stores in US, traffic strong in Canada. E-commerce doing well. Hasn't even tapped international market. Wide age demographic.

WEAK BUY

Not inexpensive. Valuation reflects growth potential; hiccups can send the stock lower. Good candidate if you want to participate in e-commerce buildout.

Disclaimer:  Christine doesn't own it. He colleague John O'Connell does.

PAST TOP PICK
(A Top Pick Nov 07/25, Down 11%)

Diagnostic testing that did so well during Covid declined, and other segments weren't strong enough to offset that. Largely behind them, but now issues in nutrition business. 

Lawsuits regarding infant formula, many being settled out of court. Plans to spin off that segment next year.

Good pipeline, M&A continues. Valuation's pulled back. Yield is 2%.

PAST TOP PICK
(A Top Pick Nov 07/25, Up 37%)

Reduced capital spending last year, which freed up some free cashflow for buybacks and dividends. Operating ratio down (good). Signed deal with CP to expand reach in Mexico in exchange for not protesting KSU merger.

PAST TOP PICK
(A Top Pick Nov 07/25, Down 12%)

Demand for new equipment has been soft, particularly in China. This changed last quarter, with other countries picking up the slack and orders in NA up by double digits. Seeing strength in modernization.